Crystal deal toy, incorporating a 3D etching of a DNA strand, commemorating the merger of biotech companies Atrin Pharmaceuticals and Aprea Therapeutics. (22ALJ234)
Crystal deal toy, incorporating a 3D etching of a DNA strand, commemorating the merger of biotech companies Atrin Pharmaceuticals and Aprea Therapeutics. (22ALJ234)
Crystal financial tombstone recognizing the acquisition of Pathology Consultants. The life sciences company is based in Greenville, South Carolina. (23AZH099)
Lucite deal tombstone marking a registered direct offering of stock by AlloVir. The clinical-stage cell therapy firm is based in Waltham, Massachusetts. (22AZH231)
Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)
Lucite deal toy commemorating the acquisition of CytoSMART, a Dutch firm specializing in live-cell imaging analysis. The acquirer, Axion BioSystems, is an Atlanta-based life sciences company. (22AZH106)
Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)
Lucite deal toy recognizing the acquisition of Cincinnati-based Advanced Testing Laboratory. ATL provides research and development services in such areas as life science, product safety, and analytical chemistry. (22AJH077)
Lucite deal toy celebrating a license option agreement between Ironwood Pharmaceuticals and COUR, a biotech firm. The agreement centers on COUR’s therapy for PBC, a rare autoimmune disease affecting the liver.
(22ALJ081)Crystal deal toy celebrating the initial public offering on the Australian Securities Exchange (ASX) of Radiopharm Theranostics. The Sydney-based company develops radiopharmaceutical drugs and treatments for cancer.
(21ALJ553)
